Myocarditis and PVP

Analysis of Anaphylaxis Reports in VAERS

  • 96% of same-day anaphylaxis reports in foreign VAERS were published only after the PVP (Pharmaco-vigilance Plan) analysis
  • 7 out of 8 anaphylaxis-related deaths were published after June 21, 2021
  • Only 25 out of 616 possible reports were considered in Pfizer’s analysis
  • Foreign reports often lack crucial data like age information
  • CDC stopped publishing EU VAERS report writeups in November 2022

Publication Timeline Analysis

Before May 18 May 18-June 21 After June 21 0.2% 1.9% 97.9%
This visualization shows the dramatic delay in publishing anaphylaxis reports. Only 0.2% were published before May 18, 2021, with 1.9% published between May 18 and June 21, and the vast majority (97.9%) published after June 21, 2021. This suggests significant delays in making these reports publicly available.

Anaphylaxis Death Reports Timeline

Total Anaphylaxis Reports (616) Death Reports (8) 1 7
Of the 8 death reports associated with anaphylaxis, 7 (87.5%) were published after June 21, 2021. This timing coincides with the PVP analysis date, suggesting these critical reports were not included in the initial safety assessment.

Missing Age Data in Foreign Reports

German Reports Age Data Complete (40%) Missing (60%)
Analysis of German reports shows a significant data quality issue: approximately 40% of reports have complete age data while 60% are missing this crucial information. This makes it difficult to perform accurate age-based analysis and potentially understates the impact on specific age groups.